Letters

Prevention of coronary heart disease

BMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7436.404-a (Published 12 February 2004) Cite this as: BMJ 2004;328:404

Statins are even less effective than paper shows

  1. David Taylor, general practitioner principal,
  2. Arnold Jenkins, general practitioner principal,
  3. Philipp Conradi, part time general practitioner (pconradi@hotmail.com)
  1. Birmingham B31 2HZ
  2. Burnley BB10 1LG
  3. Birmingham B7 5DT

    EDITOR—Marshall commendably questions current trends in preventive medicine.1 He looks at cost effectiveness of cardioprotective drug treatment, including simvastatin 40 mg, by assessing pooled data from different trials. Treatment effects are balanced with costs. The expenditure for simvastatin 40 mg is calculated as prescribing costs plus additional costs for …

    Sign in

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe